Vanucizumab (Van) In Combination With Atezolizumab (Atezo) For Platinum-Resistant Recurrent Ovarian Cancer (Proc): Results From A Single Arm Extension Phase Of The Phase I Study Bp28179

A. Oaknin,I. Vergote, I. Ray-Coquard, A. Leary, V. Rodriguez Freixinos, N. Concin, P. Toussaint,C. Massard, L. Farinas-Madrid, E. Van Nieuwenhuysen, A. Lahr, I. Franjkovic,S. Rossomanno, P. Gerber, T. Nayak, F. Heil, C. Boetsch, A. Sahbi, K. Longauer, O. Krieter

ANNALS OF ONCOLOGY（2017）

引用 6|浏览29